Literature DB >> 33057859

Brief Report: Associations Between Cognitive Control Processes and Traits of Autism Spectrum Disorder (ASD), attention-Deficit/Hyperactivity Disorder (ADHD) and Anxiety in Children at Elevated and Typical Familial Likelihood for ASD.

Priscilla B G Godoy1, Elizabeth Shephard2,3,4, Bosiljka Milosavljevic5,6,7, Mark H Johnson6,8, Tony Charman9.   

Abstract

Shared difficulties with cognitive control may play a role in co-occurring mental health problems frequently observed in autistic children. We investigated how different cognitive control processes (inhibitory control, conflict resolution, cognitive flexibility) associated with traits of autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD) and anxiety in 7-year-old children at elevated (n = 44) and typical (n = 37) familial likelihood for ASD. Poor inhibitory control was associated with higher ADHD traits. Better inhibitory control and poorer cognitive flexibility predicted higher anxiety traits. Cognitive control processes were not associated dimensionally with autistic traits, though better conflict resolution predicted greater likelihood of meeting diagnostic criteria for ASD in categorical analysis. These findings suggest that different cognitive control alterations are associated with ASD, ADHD and anxiety.

Entities:  

Keywords:  Anxiety; Attention-deficit/hyperactivity disorder (ADHD); Autism spectrum disorder (ASD); Cognitive flexibility; Conflict resolution; Inhibitory control

Mesh:

Year:  2020        PMID: 33057859     DOI: 10.1007/s10803-020-04732-9

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  22 in total

1.  Conflict monitoring and cognitive control.

Authors:  M M Botvinick; T S Braver; D M Barch; C S Carter; J D Cohen
Journal:  Psychol Rev       Date:  2001-07       Impact factor: 8.934

2.  Computational and neurobiological mechanisms underlying cognitive flexibility.

Authors:  David Badre; Anthony D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

Review 3.  The neural basis of inhibition in cognitive control.

Authors:  Adam R Aron
Journal:  Neuroscientist       Date:  2007-06       Impact factor: 7.519

Review 4.  Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V.

Authors:  Katja Beesdo; Susanne Knappe; Daniel S Pine
Journal:  Psychiatr Clin North Am       Date:  2009-09

5.  Autism Spectrum Traits Linked with Reduced Performance on Self-Report Behavioural Measures of Cognitive Flexibility.

Authors:  Natalia Albein-Urios; George J Youssef; Melissa Kirkovski; Peter G Enticott
Journal:  J Autism Dev Disord       Date:  2018-07

6.  The Development and Well-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology.

Authors:  R Goodman; T Ford; H Richards; R Gatward; H Meltzer
Journal:  J Child Psychol Psychiatry       Date:  2000-07       Impact factor: 8.982

7.  Correlation between intelligence test scores and executive function measures.

Authors:  A Ardila; D Pineda; M Rosselli
Journal:  Arch Clin Neuropsychol       Date:  2000-01       Impact factor: 2.813

8.  Compensatory neural reorganization in Tourette syndrome.

Authors:  Stephen R Jackson; Amy Parkinson; Jeyoung Jung; Suzanne E Ryan; Paul S Morgan; Chris Hollis; Georgina M Jackson
Journal:  Curr Biol       Date:  2011-04-12       Impact factor: 10.834

9.  Autism spectrum disorders: a meta-analysis of executive function.

Authors:  E A Demetriou; A Lampit; D S Quintana; S L Naismith; Y J C Song; J E Pye; I Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2017-04-25       Impact factor: 15.992

10.  The association between social cognition and executive functioning and symptoms of anxiety and depression in adolescents with autism spectrum disorders.

Authors:  Matthew J Hollocks; Catherine R G Jones; Andrew Pickles; Gillian Baird; Francesca Happé; Tony Charman; Emily Simonoff
Journal:  Autism Res       Date:  2014-03-12       Impact factor: 5.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.